BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36425561)

  • 1. The role of the endoscopic grading of gastric intestinal metaplasia in assessing gastric cancer risk: A systematic review and meta-analysis.
    Fang S; Fu Y; Du S; Wang L; Qing X; Luo X; Song G; Yang Y; Wei W
    Front Oncol; 2022; 12():1018248. PubMed ID: 36425561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic and histological risk stratification for gastric cancer using gastric intestinal metaplasia.
    Kawamura M; Uedo N; Yao K; Koike T; Kanesaka T; Hatta W; Ogata Y; Iwai W; Yokosawa S; Honda J; Asonuma S; Okata H; Ohyauchi M; Ito H; Abe Y; Ara N; Kayaba S; Shinkai H; Kanemitsu T
    J Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38740510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linked color imaging-based endoscopic grading of gastric intestinal metaplasia and histological gastritis staging in the assessment of gastric cancer risk.
    Zheng J; Zhang G; Gao C; Xu G; Lin W; Jiang C; Li D; Wang W
    Scand J Gastroenterol; 2022 Nov; 57(11):1374-1380. PubMed ID: 35701150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic grading of gastric intestinal metaplasia on risk assessment for early gastric neoplasia: can we replace histology assessment also in the West?
    Marcos P; Brito-Gonçalves G; Libânio D; Pita I; Castro R; Sá I; Dinis-Ribeiro M; Pimentel-Nunes P
    Gut; 2020 Oct; 69(10):1762-1768. PubMed ID: 32051208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric intestinal metaplasia assessment between linked color imaging based on endoscopy and pathology.
    Zhang G; Zheng J; Zheng L; Yu S; Jiang C; Lin W; Li D; Qu L; Wang W
    Scand J Gastroenterol; 2021 Jan; 56(1):103-110. PubMed ID: 33232631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and accuracy of blue light imaging for staging of intestinal metaplasia in the stomach.
    Castro R; Rodriguez M; Libânio D; Esposito G; Pita I; Patita M; Santos C; Pimentel-Nunes P; Dinis-Ribeiro M
    Scand J Gastroenterol; 2019 Nov; 54(11):1301-1305. PubMed ID: 31680561
    [No Abstract]   [Full Text] [Related]  

  • 7. Kyoto classification risk scoring system and endoscopic grading of gastric intestinal metaplasia for gastric cancer: Multicenter observation study in Japan.
    Kawamura M; Uedo N; Koike T; Kanesaka T; Hatta W; Ogata Y; Oikawa T; Iwai W; Yokosawa S; Honda J; Asonuma S; Okata H; Ohyauchi M; Ito H; Abe Y; Ara N; Kayaba S; Shinkai H; Shimokawa T
    Dig Endosc; 2022 Mar; 34(3):508-516. PubMed ID: 34415621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon footprint and cost reduction by endoscopic grading of gastric intestinal metaplasia using narrow-band imaging.
    Cho JH; Jin SY; Park S
    J Gastroenterol Hepatol; 2024 May; 39(5):942-948. PubMed ID: 38251795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study.
    Esposito G; Pimentel-Nunes P; Angeletti S; Castro R; Libânio D; Galli G; Lahner E; Di Giulio E; Annibale B; Dinis-Ribeiro M
    Endoscopy; 2019 Jun; 51(6):515-521. PubMed ID: 30577062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic diagnosis of gastric intestinal metaplasia in patients with autoimmune gastritis using narrow-band imaging: does pseudopyloric metaplasia muddy the waters?
    Dilaghi E; Esposito G; Pivetta G; Galli G; Pilozzi E; Annibale B; Lahner E
    Endosc Int Open; 2022 Apr; 10(4):E434-E440. PubMed ID: 35433221
    [No Abstract]   [Full Text] [Related]  

  • 11. Endoscopic Grading of Gastric Intestinal Metaplasia Using Magnifying and Nonmagnifying Narrow-Band Imaging Endoscopy.
    Kawamura M; Koike T; Ogata Y; Matsumoto R; Yano K; Hiratsuka T; Ohyama H; Sato I; Kayada K; Suzuki S; Hiratsuka S; Watanabe Y
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions.
    Pimentel-Nunes P; Libânio D; Lage J; Abrantes D; Coimbra M; Esposito G; Hormozdi D; Pepper M; Drasovean S; White JR; Dobru D; Buxbaum J; Ragunath K; Annibale B; Dinis-Ribeiro M
    Endoscopy; 2016 Aug; 48(8):723-30. PubMed ID: 27280384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.
    De Re V; Orzes E; Canzonieri V; Maiero S; Fornasarig M; Alessandrini L; Cervo S; Steffan A; Zanette G; Mazzon C; De Paoli P; Cannizzaro R
    Clin Transl Gastroenterol; 2016 Jul; 7(7):e183. PubMed ID: 27441820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis.
    Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
    World J Gastroenterol; 2020 Jun; 26(24):3447-3457. PubMed ID: 32655268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A deep learning model based on magnifying endoscopy with narrow-band imaging to evaluate intestinal metaplasia grading and OLGIM staging: A multicenter study.
    Niu W; Liu L; Dong Z; Bu X; Yao F; Wang J; Wu X; Chen C; Mao T; Wu Y; Yuan L; Wan X; Zhou H
    Dig Liver Dis; 2024 Feb; ():. PubMed ID: 38402085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic grading of gastric atrophy and histological gastritis staging on risk assessment for early gastric cancer: A case-control study.
    Chen M; Liu XL; Zhu XJ; Wu SR; Wang N; Li SB; Zhang LF; Liu JY; Shi YQ
    J Dig Dis; 2023 Apr; 24(4):262-270. PubMed ID: 37283197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP).
    Lee JWJ; Zhu F; Srivastava S; Tsao SK; Khor C; Ho KY; Fock KM; Lim WC; Ang TL; Chow WC; So JBY; Koh CJ; Chua SJ; Wong ASY; Rao J; Lim LG; Ling KL; Chia CK; Ooi CJ; Rajnakova A; Yap WM; Salto-Tellez M; Ho B; Soong R; Chia KS; Teo YY; Teh M; Yeoh KG
    Gut; 2022 May; 71(5):854-863. PubMed ID: 33975867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis.
    Yue H; Shan L; Bin L
    Gastric Cancer; 2018 Jul; 21(4):579-587. PubMed ID: 29460004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic Characteristics of Patients with Gastric Superficial Neoplasia and Risk Factors for Multiple Lesions after Endoscopic Submucosal Dissection in a Western Country.
    Brito-Gonçalves G; Libânio D; Marcos P; Pita I; Castro R; Sá I; Dinis-Ribeiro M; Pimentel-Nunes P
    GE Port J Gastroenterol; 2020 Feb; 27(2):76-89. PubMed ID: 32266305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.